We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Otsuka Seeks Re-Examination Of Abilify Patent Due To Error In Original Filing

Law360 (September 6, 2004, 12:00 AM EDT) -- Japanese drug maker Otsuka Pharmaceutical Co. has filed a request with the U.S. Patent and Trademark Office for a re-examination of the basic U.S. composition of matter patent covering Abilify (aripiprazole),...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.